Nobivac Tri Cat Trio

Nobivac Tri Cat Trio is a core modified-live vaccine developed to protect cats against three serious viral diseases: feline herpesvirus (feline rhinotracheitis), calicivirus, and feline panleukopenia. These infections can cause severe respiratory illness, fever, and other life-threatening complications in cats. The vaccine is commonly administered to kittens from around 8–9 weeks of age as part of a routine vaccination program.

This vaccine works by stimulating the cat’s immune system to build protection against these viruses. It helps reduce the risk of respiratory infections and severe gastrointestinal disease caused by feline panleukopenia. Regular vaccination helps maintain long-term immunity and supports better health in both kittens and adult cats.

Nobivac Tri Cat Trio is included among veterinary pharmaceutical products designed to support preventive healthcare in companion animals. Its reliable formulation and proven protective action make it a trusted option among veterinary pharmaceutical products used by veterinary professionals for feline vaccination programs.

Product Features

• Modified-live vaccine for cats
• Protects against three major feline viral diseases
• Effective against feline herpesvirus, calicivirus, and panleucopenia
• Suitable for kittens from 8–9 weeks of age
• Helps support long-term immunity
• Commonly used in routine feline vaccination programs

How It Helps

• Protects cats against feline rhinotracheitis (herpesvirus infection)
• Helps prevent calicivirus-related respiratory infections
• Provides immunity against feline panleukopenia
• Supports long-term disease prevention and feline health